Log in
NASDAQ:NEOG

Neogen Stock Forecast, Price & News

$73.57
-1.13 (-1.51 %)
(As of 09/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$72.67
Now: $73.57
$75.16
50-Day Range
$73.23
MA: $76.22
$81.89
52-Week Range
$48.91
Now: $73.57
$82.06
Volume184,772 shs
Average Volume215,357 shs
Market Capitalization$3.90 billion
P/E Ratio65.11
Dividend YieldN/A
Beta0.62
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed, and grain processors and processors; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topical and diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing, Michigan.
Read More
Neogen logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.2Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.18 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:NEOG
CUSIP64049110
Phone517-372-9200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$418.17 million
Cash Flow$1.42 per share
Book Value$13.76 per share

Profitability

Net Income$59.47 million

Miscellaneous

Employees1,764
Market Cap$3.90 billion
Next Earnings Date12/28/2020 (Estimated)
OptionableOptionable
$73.57
-1.13 (-1.51 %)
(As of 09/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NEOG News and Ratings via Email

Sign-up to receive the latest news and ratings for NEOG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Neogen (NASDAQ:NEOG) Frequently Asked Questions

How has Neogen's stock price been impacted by Coronavirus?

Neogen's stock was trading at $60.73 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NEOG stock has increased by 21.1% and is now trading at $73.57.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Neogen?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neogen in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Neogen
.

When is Neogen's next earnings date?

Neogen is scheduled to release its next quarterly earnings announcement on Monday, December 28th 2020.
View our earnings forecast for Neogen
.

How were Neogen's earnings last quarter?

Neogen Co. (NASDAQ:NEOG) issued its quarterly earnings results on Tuesday, September, 22nd. The company reported $0.30 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.28 by $0.02. The business earned $109.33 million during the quarter, compared to analyst estimates of $105.79 million. Neogen had a net margin of 14.22% and a return on equity of 8.53%. Neogen's revenue for the quarter was up 7.8% on a year-over-year basis. During the same period last year, the business earned $0.28 EPS.
View Neogen's earnings history
.

When did Neogen's stock split? How did Neogen's stock split work?

Neogen shares split on Tuesday, January 2nd 2018. The 4-3 split was announced on Friday, December 8th 2017. The newly created shares were payable to shareholders after the closing bell on Friday, December 29th 2017. An investor that had 100 shares of Neogen stock prior to the split would have 133 shares after the split.

How will Neogen's stock buyback program work?

Neogen declared that its Board of Directors has initiated a stock buyback program on Wednesday, October 10th 2018, which authorizes the company to buyback 3,000,000 shares, according to EventVestor. This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock buyback programs are often a sign that the company's board believes its shares are undervalued.

What price target have analysts set for NEOG?

3 brokers have issued 12 month price objectives for Neogen's shares. Their forecasts range from $75.00 to $88.00. On average, they expect Neogen's share price to reach $81.50 in the next year. This suggests a possible upside of 10.8% from the stock's current price.
View analysts' price targets for Neogen
.

Who are some of Neogen's key competitors?

What other stocks do shareholders of Neogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neogen investors own include NVIDIA (NVDA), Nike (NKE), Pfizer (PFE), AT&T (T), AbbVie (ABBV), Boeing (BA), JPMorgan Chase & Co. (JPM), WP Carey (WPC), Advanced Micro Devices (AMD) and Costco Wholesale (COST).

Who are Neogen's key executives?

Neogen's management team includes the following people:
  • Mr. James L. Herbert, Exec. Chairman (Age 79)
  • Mr. John Edward Adent, CEO & Pres (Age 51)
  • Mr. Steven J. Quinlan, VP, CFO & Sec. (Age 57)
  • Ms. Terri A. Morrical, VP of Animal Safety Operations (Age 54)
  • Mr. Rod Poland, Director of Corp. Communications

What is Neogen's stock symbol?

Neogen trades on the NASDAQ under the ticker symbol "NEOG."

Who are Neogen's major shareholders?

Neogen's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (10.60%), Wasatch Advisors Inc. (3.46%), Conestoga Capital Advisors LLC (3.28%), Riverbridge Partners LLC (2.38%), Neuberger Berman Group LLC (1.95%) and New York State Common Retirement Fund (1.64%). Company insiders that own Neogen stock include Jack C Parnell, James L Herbert, James P Tobin, Jason Warren Lilly, John Edward Adent, Steven J Quinlan, Terri A Morrical, Thomas H Reed and William T Boehm.
View institutional ownership trends for Neogen
.

Which institutional investors are selling Neogen stock?

NEOG stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Bamco Inc. NY, Goldman Sachs Group Inc., Vanguard Group Inc., CIBC Private Wealth Group LLC, Stephens Investment Management Group LLC, Prudential Financial Inc., and Russell Investments Group Ltd.. Company insiders that have sold Neogen company stock in the last year include James L Herbert, Jason Warren Lilly, Steven J Quinlan, Terri A Morrical, Thomas H Reed, and William T Boehm.
View insider buying and selling activity for Neogen
.

Which institutional investors are buying Neogen stock?

NEOG stock was acquired by a variety of institutional investors in the last quarter, including Glenmede Trust Co. NA, Conestoga Capital Advisors LLC, Man Group plc, Mitsubishi UFJ Trust & Banking Corp, First Trust Advisors LP, Raymond James & Associates, Nuveen Asset Management LLC, and Mackay Shields LLC. Company insiders that have bought Neogen stock in the last two years include James P Tobin, and John Edward Adent.
View insider buying and selling activity for Neogen
.

How do I buy shares of Neogen?

Shares of NEOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Neogen's stock price today?

One share of NEOG stock can currently be purchased for approximately $73.57.

How big of a company is Neogen?

Neogen has a market capitalization of $3.90 billion and generates $418.17 million in revenue each year. The company earns $59.47 million in net income (profit) each year or $1.13 on an earnings per share basis. Neogen employs 1,764 workers across the globe.

What is Neogen's official website?

The official website for Neogen is www.neogen.com.

How can I contact Neogen?

Neogen's mailing address is 620 LESHER PLACE, LANSING MI, 48912. The company can be reached via phone at 517-372-9200 or via email at [email protected]

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.